The Patent Cliff Isn’t a Pipeline Problem. It’s a Leadership Problem
[…]
Medical Affairs
We identify medical affairs leaders who bridge science and clinical practice translating data into insight for physicians, payers, and internal teams alike.
As payers and physicians demand more real-world evidence before adopting new therapies, medical affairs has moved from a post-launch support function to a strategic partner shaping evidence generation from early development onward.
Recent placements:
- VP US & Global Medical Affairs, Global pharma
- Director of Medical Science Liaisons, Global pharma
Approach
Execruit prioritised candidates who had already built or scaled a medical affairs function from the ground up, rather than experienced generalists, given the tight runway to launch.
Outcome
The hire joined in time to stand up the field medical team ahead of the indication expansion, with the launch proceeding on the client's original timeline.
This practice draws on Signe Reidla's Medical Doctor training and her experience guiding a novel antiviral through global approval and into commercial use at F. Hoffmann-La Roche AG — direct, clinical grounding in how scientific data becomes evidence physicians, payers and patients can act on, which shapes how Execruit evaluates medical affairs talent.
